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ABSTRACT
Objectives: The aim of this research is to study duck eggwhite potential in treating subacute lead poisoning.
Methods: The potential of duck egg white was evaluated from the red blood cell profile and the clinical signs that emerged. The research used thirty male rats 
which were divided into 6 groups and 5 replications (i.e. rats as control, rats administrated only with lead, rats administrated with lead and antidote). Each 
of the four treatment groups were given one antidote (i.e. EDTA, 50% egg white, 75% egg white, and 100% egg white). Lead force feeding was conducted for 
15 days, followed by the administration of the antidote for the same duration of 15 days, and concluded with blood sampling at the end of each treatment.
Results: There was no significant effect on haemoglobin but lead decreased total red blood cells (p<0.05) in subacute lead poisoning. Rats that were 
given 75% and 100% duck egg white as an antidote showed an increase in total red blood cell counts in addition to a faster recovery.
Conclusion: High concentration of duck egg white had shown positive results as an antidote for subacute lead poisoning.
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INTRODUCTION
Lead poisoning case has been frequently reported on human and 
animal alike [1]. Industrial manufacturing and motor vehicle exhaust 
turned lead into one of the largest environmental pollutions. Lead 
poisoning from work environment (work-related poisoning) may 
happen in battery industry, paint industry, printing, pottery, and lead 
smelting [2]. Lead exposure may happen during tank building process, 
pipe installment, and other activities with equipment harboring gas 
and liquid with corrosive superconductor properties, optical fiber 
technology, magnetic resonance imaging, and nuclear drugs. Lead can 
inadvertently contaminate body through polluted air, lead inhalation, 
skin contact, contaminated food and drinks, and swallowed lead-
containing matter [3,4].
Lead accumulation within the body may cause acute and chronic 
poisoning, even death. The effect of acute and subacute lead poisoning 
is very particular in relation to the relatively high dosage exposure and 
relatively short exposure duration, whether it is counted in days or 
months. Acute lead poisoning effect may also occur dramatically in the 
form of sudden death, severe stomach cramp, anemia, behavioral change, 
and loss of appetite. In the event of lead poisoning, described effects may 
not all manifest and only some of them are clearly observable [5].
Chronic lead poisoning effects happen as a result of small amount 
of lead exposure for long period. It may happen in months or years. 
Chronic lead poisoning usually caused unspecific symptoms on almost 
every body system. Negative effects of lead poisoning in human based 
on a research by Pokras and Kneeland [1] consist of lowering libido and 
fertility (male and female), stillbirth and premature birth, intelligence 
impairment, hypertension, cardiovascular disease, aggression, and 
impaired renal function.
Generally, chelation therapy is a preferred medical treatment chosen to 
minimize toxic effect of heavy metal including lead [6]. Chelation agent 
can bind heavy metal ion within cell or outside cell, forming complex 
structure which is easily excreted outside the body [7]. Chelation agent 
can be administered intravenously, intramuscularly, through inhalation, 
or orally depending on the type of drugs. Several types of chelating agent 
had been proven effective. Calcium disodium ethylendiaminetetraacetic 
acid (EDTA), calcium trisodium diethylenetriaminepentaacetic acid, 
British anti-Lewisite, unithiol, EDTA, penicillamine, and succimer are 
several examples of chelating agent [7,8]. Main chelating agent most 
commonly used in hospital are usually administered parenterally (not 
orally) by trained medical staff. On the other hand, oral chelating agent 
can be used without special equipment and treatment, but its dosage 
must be a point of consideration.
Till date, chelating agents are generally expensive, cannot be obtained 
without prescription, not continually available, and available in 
restricted amount. With the aforementioned constraints, human and 
animal alike suffering from lead poisoning cannot be treated quickly 
and precisely. Delay of lead poisoning therapy may increase absorption 
and accumulation of lead within the body which can result in fatal 
consequence or even death [9].
The ability of protein to bond with heavy metal is the basis in finding 
alternative for effective heavy metal poisoning treatment which is 
safe, cheap, and easily obtainable. One of natural proteins potential to 
be used as heavy metal chelating agent is duck egg. Duck egg white is 
reported to have higher protein content compared to chicken egg [10]. 
In addition, duck egg is also commonly consumed and favored by 
people with relatively affordable price. Thus, research that study duck 
egg white potential in treating lead poisoning must be conducted. The 
aim of this research is to study duck egg white potential in treating 
subacute lead poisoning.
METHODS
Research was conducted in Laboratory Animal Management Unit, 
Pharmacology Laboratory, and Physiology Laboratory, Veterinary 
Medicine Faculty, Bogor Agricultural University. Animal used were 
30 male rats (Rattus novergicus) of Sprague-Dawley strain. Materials 
used are duck egg white, lead acetate (Pb(CH3COO)2), Na-EDTA, aqua 
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distillate, and blood test reagent. Equipment used is maintenance cage, 
test tubes, 1 ml, 3 ml, and 5 ml syringes, bowls, plastic glass, napkins, 
gastric sonde, squeeze cages for rat, macro- and micro-scale, volumetric 
flask, stationery, ice box, counting chamber, microscope, capillary pipe, 
microcapillary hematocrit reader, and spectrophotometer.
Preparing 1000 ppm lead acetate
1000 ppm lead acetate solution was made by diluting 1 g lead acetate 
crystal within 1000 ml aqua distillate. Lead acetate crystal and aqua 
distillate were mixed inside volumetric flask and then stirred until they 
homogenized.
Rat preparation and group division
Thirty male rats were chosen and reared for 2 weeks for acclimatization. 
All rats have relatively similar body weight (BW) of 180-240 g. Rats were 
given standard feed and water given ad libitum. Rats were separated into 
six treatment groups with five rats for each treatment. Treatment 1 was 
control group, which are rats that were not exposed to lead and did not 
received duck egg whites or EDTA. Animal divided into six groups of five 
rats each. Group I: normal control rats were not exposed to lead and did 
not received duck egg whites or EDTA; Group II: Lead control rats given 
lead exposure; Group III: rats given lead exposure and administered 
EDTA; Group IV; rats given lead exposure and administered duck egg 
white (50%); Group V; rats given lead exposure and administered duck 
egg white (75%), Group VI; rats given lead exposure and administered 
duck egg white (100%).
Lead exposure
Exposure to lead was done by force feeding treatment rats by lead 
acetate (1000 ppm) for 15 days with 15 mg/100 g BW dosage. 
Dosage was calculated based on dosage conversion by Laurence and 
Bacharah [11]. After 15 days of lead exposure, the rats were given EDTA 
or duck egg white depending on their treatment group.
Red blood count and clinical symptoms observation
Blood count was conducted 3 times: Before treatment (day-0), after 
lead acetate administration (day 15 post administration), and after 
EDTA or duck egg white administration (day 15 post treatment). Blood 
count consists of red blood cell count, hematocrit, and hemoglobin (Hb) 
count. Clinical symptom observation of lead poisoning (lethargy and 
diarrhea) was done every week during the observation.
Blood collection was done through coccygeal lateralis vein by the tail 
from rats placed inside squeeze cages. Obtained blood samples were 
transferred into tubes containing EDTA anticoagulant. Afterward, 
method on erythrocyte count, Hb count, and hematocrit were conducted 
as follows.
Erythrocyte count
Erythrocyte count was done using hemocytometer (counting chamber). 
As much as 2.5 µl blood was homogenized with 0.5 ml Hayem’s 
solution to reached 200 times dilution. Blood that has been diluted 
was dropped into hemocytometer and checked under microscope with 
400 times magnification. The number of erythrocyte was counted from 
5 erythrocyte box diagonally or all four sides and the middle box of 
counting chamber. Total erythrocyte count was obtained by multiplying 
the number of erythrocyte observed with 10,000/mm3.
Hb count
Hb count was measured by cyanomethemoglobin method. As much 
as, 20 µl of blood was mixed into 5 ml of cyanomethemoglobin 
reagent and then homogenized. The absorbance value was read using 
spectrophotometer under 540 nm wavelength. Hb count was obtained 
by multiplying absorbance value with 36.8 g Hb/100 ml.
Hematocrit measurements
Hematocrit was measured using microcapillary method. Microcapillary 
pipette coated with heparin was dipped inside sample blood up to 2/3 
of pipette were filled. The microcapillary pipette was centrifuged in 
12,000 rpm for 5 minutes. Hematocrit was obtained from microcapillary 
hematocrit reader.
Observed variable
Variables observed in this research are specific clinical symptoms 
(lethargy and diarrhea) and red blood cell count (erythrocyte count, Hb 
count, and hematocrit).
Data analysis
Obtained data were analyzed by analysis of variance and followed by 
Duncan test. Data obtained were analyzed descriptively.
RESULTS
Anemia as one of the lead poisoning clinical symptoms can be recognized 
through blood count. Blood count was done to see red blood cell profile 
after lead acetate force feeding and after duck egg white administration. 
Red blood cell profile is presented on Table 1.
Post lead force feeding blood count showed a decrease of erythrocyte 
count (p<0.05). Rat Hb count in lead given rats is significantly different 
compared to other treatment group rats. There is no significantly 
different result in hematocrit between treatment groups. Post antidote 
administration, erythrocyte count was seen increasing except in rats 
given lead acetate and 50% duck egg white (p<0.05). The increase of 
erythrocyte in rats given 100% duck egg white is higher compared to 
rats given EDTA. 
Hb count does not have good correlation with lead content in blood 
which cause anemia to not manifest in low lead exposure [12]. 
Mugahi et al. [13] explained that lead poisoning can cause decrease 
in erythrocyte and Hb count. Anemia that commonly happens is 
normocytic-normochromic anemia in subclinical phase, hypochromic 
anemia in acute phase, and macrocytic hypochromic anemia or 
normocytic-normochromic in chronic phase. Microcytic-hypochromic 
anemia happens in young with iron deficiency. Erythrocyte index of 
white rats in this research is presented in Table 2.
Identification of subacute lead poisoning cannot be easily identified 
from blood count profile alone since anemia was not clearly observable. 
Lead poisoning diagnosis cannot be upheld without other supporting 
evidence, for example lead content in blood and protophorphyrin 
enzyme. Manifestation of clinical symptoms is a sign of lead accumulation 
of at least 200 mg/kg KB in rats [13]. Clinical symptoms’ observation 
was conducted based on treatment group and not individually. Clinical 
symptoms’ observation during research result is presented in Table 3.
Table 3 showed that control rat did not present lead clinical symptoms. 
All rats that were given lead for 15 days showed lethargy and diarrhea. 
Rats with lethargy appeared to be more apathetic and weaker. Before 
the symptoms, rats were very active, ran around, and struggled during 
handling. Diarrhea was seen from watery excrement left around anus or 
tail. Watery excrement also mixed with woodchip bedding, which piled 
with one another. Clinical symptoms did not appear after 7 days of 75% 
and 100% duck egg white administration. Lethargy still appeared on 
rats only given lead, rats given lead and EDTA, and rats given lead and 
50% duck egg white. Diarrhea only appeared in rats given only lead.
DISCUSSION
The decrease of erythrocyte count presumably happened as a result of 
lead in the bloodstream that disrupted hematopoiesis enzyme. Increase 
of reactive oxidative species perpetrated by free radical lead ion can cause 
red blood cell damage as explain by Weiss and Wardrop [14,15]. Hb tends 
not to be affected in subacute lead poisoning since there was enough time 
for body to regenerate. In this research, there is no decrease Hb in rats 
forcefed by lead. The form of anemia observed also varied; however, none 
exhibit anemia caused by lead poisoning. Rats given only lead suffered 
from macrocytic-hypochromic anemia while rats given lead and antidote 
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suffered from macrocytic-hyperchromic anemia. This difference of anemia 
type was caused by different blood count parameter value.
Lead can replace calcium and disrupt calcium and calcium ion canal on 
cell membrane which cause intestine cells function impairment [16]. 
Lead in body can disrupt cell normal function, especially smooth 
muscle contraction and neurotransmitter release. Diarrhea happens 
because decreasing water absorption in colon caused by colon motility 
impairment. This resulted in higher water content in the feces. Intestine 
motility impairment lowered nutrition absorption into cell. This causes 
energy to no longer able to support rat activity. Prolonged diarrhea 
increased water loss and caused dehydration and lethargy. Lethargy 
is also caused by muscle cell contraction impairment because lowered 
cell calcium.
From the result of this research, 75% and 100% duck egg white antidote 
administration able to eliminate clinical symptoms in rats. Protein in 
duck egg white is presumed to catch lead ion remaining at the surface 
Table 1: Erythrocyte count, Hb count, and hematocrit profile
Parameter Control Lead Lead treatment+ p
EDTA Egg 50% Egg 75% Egg 100%
Before treatment
Erythrocyte (juta/mm3) 8.2±1.99a 8.3±0.62a 7.4±1.09a 6.9±0.47a 7.7±0.65a 8.2±1.11a 0.327
Hb (g%) 14.4±2.67a 14.7±0.40a 15.1±1.01a 14.1±1.37a 14.4±0.74a 14.4±0.47a 0.893
Hematocrit (%) 39.8±2.08a 39.3±3.45a 38.9±3.88a 41.4±1.39a 39.6±2.13a 37.6±4.55a 0.583
After lead force feeding
Erythrocyte (juta/mm3) 8.9±0.79a 8.8±1.62a 5.9±1.35b 7.4±1.31ab 6.6±1.61b 7.8±0.71ab 0.008
Hb (g%) 14.1±1.02ab 12.9±2.38ab 15.7±1.74a 15.2±0.81a 15.6±1.21a 14.7±0.72ab 0.048
Hematocrit (%) 40.9±1.49a 41.0±4.94a 40.8±3.16a 38.1±4.15a 39.2±2.62a 42.3±1.96a 0.429
After duck egg white administration
Erythrocyte (juta/mm3) 7.4±0.14cd 8.9±0.67a 8.0±0.37bc 7.1±1.01d 7.7±0.39bcd 8.2±0.40ab 0.001
Hb (g%) 13.5±1.17a 14.8±0.47a 14.7±0.49a 13.5±0.42a 13.9±2.32a 13.7±0.39a 0.277
Hematocrit (%) 40.8±1.95b 43.5±1.62a 42.3±0.74ab 41.1±2.42ab 43.1±0.74ab 38.5±1.97c 0.001
Different superscripted letter on the same row showed significantly different result (p<0.05). Hb: Hemoglobin, EDTA: Ethylendiaminetetraacetic acid
Table 2: Rat erythrocyte index
Parameter Control Lead Lead treatment+ p
EDTA Egg 50% Egg 75% Egg 100%
Before treatment
MCV (fl) 50.5±10.04a 47.8±5.27a 53.3±8.32a 60.3±4.77a 51.7±6.59a 46.1±7.09a 0.071
MCH (pg) 18.1±3.34a 17.8±1.15a 20.7±2.88a 20.5±2.32a 18.7±1.80a 17.7±2.50a 0.208
MCHC (%) 36.4±6.94a 37.6±4.00a 39.3±5.82a 34.2±3.70a 36.3±1.58a 38.6±4.32a 0.586
After lead forcefeeding
MCV (fl) 46.3±4.75b 47.3±4.63b 40.8±22.26a 52.2±7.21b 60.9±9.65ab 54.9±5.13b 0.010
MCH (pg) 15.9±1.80cd 14.9±2.55d 27.5±7.12a 20.8±2.86bc 24.4±5.18ab 19.0±1.96bcd 0.000
MCHC (%) 34.5±3.63ab 31.7±4.67b 38.8±5.06a 40.0±3.61a 39.9±4.26a 34.6±1.28ab 0.011
After duck egg white administration
MCV (fl) 55.2±2.56a 48.9±2.81b 52.8±3.38ab 58.5±8.44a 56.5±2.91a 46.9±3.63b 0.003
MCH (pg) 18.3±1.31a 16.7±1.04a 18.3±1.40a 19.3±2.95a 18.2±3.41a 16.7±1.16a 0.362
MCHC (%) 33.1±1.95a 34.1±1.50a 34.6±0.72a 32.9±1.86a 32.2±5.26a 35.7±1.04a 0.304
Different superscripted letter in the same row showed significantly different result (p<0.05). MCHC: Mean corpuscular hemoglobin concentration, MCH: Mean 
corpuscular hemoglobin, MCV: Mean corpuscular volume, EDTA: Ethylendiaminetetraacetic acid
Table 3: Clinical symptoms observed in treatment group during research
Clinical symptoms Treatment
Control Lead (%) Lead+EDTA (%) Egg 50% (%) Egg 75% (%) Egg 100% (%)
Day 0
Lethargy* - - - - - -
Diarrhea* - - - - - -
Day 7 post lead force feeding
Lethargy - - - - - -
Diarrhea - - - - - -
Day 15 post lead force feeding (Day 0 of 
duck egg white administration)
Lethargy - +(100) +(100) +(100) +(100) +(100)
Diarrhea - +(80) +(60) +(60) +(80) +(60)
Day 7 post duck egg white administration
Lethargy - +(40) +(20) +(40) - -
Diarrhea - +(20) - - - -
Day 15 post duck egg white administration
Lethargy - - - - - -
Diarrhea - - - - - -
*Showed that change was not caused by treatment. EDTA: Ethylendiaminetetraacetic acid
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of intestines and prevent it from being absorb into bloodstream. Fat 
and protein contained in duck egg white presumably help in supplying 
energy to rats, which prevent lethargy.
Other apparent lead poisoning clinical symptoms is severe colic; 
however, colic is not generally seen in adult [17]. Egg proteins 
especially lysozyme, ovalbumin, and ovotransferrin are the best heavy 
metal chelator contained in egg. Through sulfhydryl bond, protein will 
trap metal ion in gastrointestinal tract [18]. Other than protein, fat is 
also abundant in duck egg white. Fat and protein content in duck egg 
white is higher than chicken egg and low in cholesterol [10]. The lack 
of protein intake reported to cause diarrhea; thus, exogenous protein 
intake is hoped to fix the condition [19].
In this research, colic symptom was unobservable because the rats used 
were reaching adulthood. Adult rat only absorbs 10% of lead consumed 
and the rest will be excreted through urine and feces [20,21]. Lead 
administration in this research used 15 mg/100 g BW for 15 days, or 
subacute period, while colic usually happened in acute lead poisoning 
case in young animal. Subacute lead poisoning did not present specific 
clinical symptoms which broadened differential diagnosis.
CONCLUSION
75% and 100% duck egg white have the potential as antidote 
for subacute lead poisoning. Duck egg white can able to increase 
erythrocyte count in rat force-fed by lead (p<0.05). Duck egg white 
contains protein that can bind and prevent lead metal ion absorption 
and thus prevent further blood destruction. Fat and protein contained 
in duck egg white are presumed to be high energy supply which can 
treat clinical symptoms in subacute lead poisoning.
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